Erratum to "A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib"

Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens.

Blood neoplasia·2026

Treatment intensity, illness burden, and disparities in newly diagnosed diffuse large B-cell lymphoma treated at an urban academic center.

Leukemia & lymphoma·2026

Are CHOP-plus really CHOP-minus propositions in the treatment of PTCL? A comprehensive assessment of the strategy.

Blood advances·2026

Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.

Blood neoplasia·2025

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Blood·2025

Life-Threatening Cytopenias in a Jehovah's Witness Following CD19-Directed Chimeric Antigen Receptor T Cell Therapy.

EJHaem·2025

Renal Outcomes Following Autologous Stem Cell Transplantation in Dialysis-Dependent Patients With Multiple Myeloma: A Single-Center Study From a Low- and Middle-Income Country.

Case reports in hematology·2026

Refractory Hypereosinophilic Syndrome With Clonal T-Cell Receptor Rearrangement Treated With JAK Inhibition Following Incomplete Response to IL-5 Blockade.

Case reports in hematology·2026

Celiac Disease Emerging After ASCT in Multiple Myeloma: A Rare Diagnostic Intersection and Literature Review.

Case reports in hematology·2026

Congenital Dyserythropoietic Anemia Type II Caused by a New SEC23B Sequence Variant.

Case reports in hematology·2026

Cutaneous Clue to Clonal Evolution: Sweet's Syndrome Heralding Hematologic Progression in Essential Thrombocythemia.

Case reports in hematology·2026

Double Heterozygous CDAN1 Variants of Uncertain Significance Associated With a Phenotype Consistent With Congenital Dyserythropoietic Anemia Type 1.

Case reports in hematology·2026

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Frontiers in medicine·2026

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

BMC gastroenterology·2026

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

MedScience·2026

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

Journal of neurointerventional surgery·2026

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Colloids and surfaces. B, Biointerfaces·2026

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Cancer treatment and research communications·2026

Related Experiment Videos

Erratum to "A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib"

Related Concept Videos

Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens.

Treatment intensity, illness burden, and disparities in newly diagnosed diffuse large B-cell lymphoma treated at an urban academic center.

Are CHOP-plus really CHOP-minus propositions in the treatment of PTCL? A comprehensive assessment of the strategy.

Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Life-Threatening Cytopenias in a Jehovah's Witness Following CD19-Directed Chimeric Antigen Receptor T Cell Therapy.

Renal Outcomes Following Autologous Stem Cell Transplantation in Dialysis-Dependent Patients With Multiple Myeloma: A Single-Center Study From a Low- and Middle-Income Country.

Refractory Hypereosinophilic Syndrome With Clonal T-Cell Receptor Rearrangement Treated With JAK Inhibition Following Incomplete Response to IL-5 Blockade.

Celiac Disease Emerging After ASCT in Multiple Myeloma: A Rare Diagnostic Intersection and Literature Review.

Congenital Dyserythropoietic Anemia Type II Caused by a New SEC23B Sequence Variant.

Cutaneous Clue to Clonal Evolution: Sweet's Syndrome Heralding Hematologic Progression in Essential Thrombocythemia.

Double Heterozygous CDAN1 Variants of Uncertain Significance Associated With a Phenotype Consistent With Congenital Dyserythropoietic Anemia Type 1.

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Related Experiment Videos

Erratum to "A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib"

Related Concept Videos

Related Articles